TY - CHAP
T1 - Neurocomputational Models of Schizophrenia
AU - Moustafa, Ahmed Abdelhaim
AU - Misiak, Błażej
AU - Frydecka, Dorota
PY - 2018
Y1 - 2018
N2 - Schizophrenia is a complex neurodevelopmental disorder with relatively stable prevalence rates estimated at about 0.5% (Saha, Chant, Welham, & McGrath, 2005). Schizophrenia is characterized by co-occurrence of multiple psychopathological symptoms that have been conceptualized as positive symptoms (delusions and hallucinations), negative symptoms (e.g., apathy, avolition, affective flattening, and social withdrawal), affective symptoms and cognitive impairment. These dimensions of schizophrenia psychopathology have complex underlying neural substrates. For instance, alterations in frontotemporal cortical networks have been most consistently related to negative symptoms (Millan, Fone, Steckler, & Horan, 2014), while aberrant neurotransmission within basal ganglia (Perez-Costas, Melendez-Ferro, & Roberts, 2010) and the hippocampus (Heckers, 2001) has been shown to underlie positive symptoms. More complex neural substrates have been shown for the cognitive impairment that is present in about 80% of patients and affects several domains of cognitive performance including attention, memory, reasoning, and processing speed (Barch & Ceaser, 2012; Bora, Yucel, & Pantelis, 2010; Keefe & Fenton, 2007; Keefe & Harvey, 2012).
AB - Schizophrenia is a complex neurodevelopmental disorder with relatively stable prevalence rates estimated at about 0.5% (Saha, Chant, Welham, & McGrath, 2005). Schizophrenia is characterized by co-occurrence of multiple psychopathological symptoms that have been conceptualized as positive symptoms (delusions and hallucinations), negative symptoms (e.g., apathy, avolition, affective flattening, and social withdrawal), affective symptoms and cognitive impairment. These dimensions of schizophrenia psychopathology have complex underlying neural substrates. For instance, alterations in frontotemporal cortical networks have been most consistently related to negative symptoms (Millan, Fone, Steckler, & Horan, 2014), while aberrant neurotransmission within basal ganglia (Perez-Costas, Melendez-Ferro, & Roberts, 2010) and the hippocampus (Heckers, 2001) has been shown to underlie positive symptoms. More complex neural substrates have been shown for the cognitive impairment that is present in about 80% of patients and affects several domains of cognitive performance including attention, memory, reasoning, and processing speed (Barch & Ceaser, 2012; Bora, Yucel, & Pantelis, 2010; Keefe & Fenton, 2007; Keefe & Harvey, 2012).
M3 - Chapter
SN - 978-1-119-15906-3
SP - 73
EP - 84
BT - Computational Models of Brain and Behavior
A2 - Moustafa, Ahmed A.
PB - Wiley-Blackwell
ER -